Drug Enforcement Administration October 2024 – Federal Register Recent Federal Regulation Documents

Possible Control of Phenethyl Bromide as a List I Chemical
Document Number: 2024-24616
Type: Proposed Rule
Date: 2024-10-28
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) finds that phenethyl bromide is used in the illicit manufacture of the controlled substance fentanyl, as well as fentanyl analogues and fentanyl-related substances, and is important to the manufacture of these substances because it is often used in synthetic pathways to illicitly manufacture fentanyl, fentanyl analogues, and fentanyl-related substances. Prior to proposing to list phenethyl bromide as a list I chemical under the Controlled Substances Act, DEA is soliciting information on the current uses of phenethyl bromide (other than for the synthesis of fentanyl) in order to properly determine the effect such a proposed action would have on legitimate industry.
Schedules of Controlled Substances: Placement of Butonitazene, Flunitazene, and Metodesnitazene Substances in Schedule I
Document Number: 2024-24635
Type: Rule
Date: 2024-10-25
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration places butonitazene, flunitazene, and metodesnitazene including their isomers, esters, ethers, salts and salts of isomers, esters and ethers in schedule I of the Controlled Substances Act. The regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess), or propose to handle these three specific controlled substances will continue to apply as a result of this action.
BRX Pharmacy; Decision and Order
Document Number: 2024-24564
Type: Notice
Date: 2024-10-23
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Halo Pharmaceutical Inc.
Document Number: 2024-24560
Type: Notice
Date: 2024-10-23
Agency: Drug Enforcement Administration, Department of Justice
Halo Pharmaceutical Inc. to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Mylan Technologies Inc
Document Number: 2024-24557
Type: Notice
Date: 2024-10-23
Agency: Drug Enforcement Administration, Department of Justice
Mylan Technologies Inc to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
David Carlos Rodriguez, M.D.; Decision and Order
Document Number: 2024-24575
Type: Notice
Date: 2024-10-23
Agency: Drug Enforcement Administration, Department of Justice
Itani Family Pharmacy, PLC; Decision And Order
Document Number: 2024-24572
Type: Notice
Date: 2024-10-23
Agency: Drug Enforcement Administration, Department of Justice
Dale Fitzpatrick, M.D.; Decision and Order
Document Number: 2024-24570
Type: Notice
Date: 2024-10-23
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Irvine Labs, Inc.
Document Number: 2024-24554
Type: Notice
Date: 2024-10-23
Agency: Drug Enforcement Administration, Department of Justice
Irvine Labs, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Irvine Labs, Inc.
Document Number: 2024-24553
Type: Notice
Date: 2024-10-23
Agency: Drug Enforcement Administration, Department of Justice
Irvine Labs, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Schedules of Controlled Substances: Placement of Ethylphenidate in Schedule I
Document Number: 2024-24083
Type: Rule
Date: 2024-10-22
Agency: Drug Enforcement Administration, Department of Justice
With the issuance of this final rule, the Drug Enforcement Administration places ethylphenidate (chemical name: ethyl 2-phenyl-2- (piperidin-2-yl)acetate), including its salts, isomers, and salts of isomers, in schedule I of the Controlled Substances Act. This action is being taken, in part, to enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substances. When finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle ethylphenidate.
Neeraj B. Shah, M.D.; Decision and Order
Document Number: 2024-24189
Type: Notice
Date: 2024-10-21
Agency: Drug Enforcement Administration, Department of Justice
Janet S. Pettyjohn, D.O.; Decision and Order
Document Number: 2024-23511
Type: Notice
Date: 2024-10-11
Agency: Drug Enforcement Administration, Department of Justice
William J. Mack, M.D.; Decision and Order
Document Number: 2024-23515
Type: Notice
Date: 2024-10-11
Agency: Drug Enforcement Administration, Department of Justice
Robert P. Hansen, M.D.; Decision and Order
Document Number: 2024-23514
Type: Notice
Date: 2024-10-11
Agency: Drug Enforcement Administration, Department of Justice
Michael Berman, D.O.; Decision and Order
Document Number: 2024-23513
Type: Notice
Date: 2024-10-11
Agency: Drug Enforcement Administration, Department of Justice
Midtown Specialty RX; Decision and Order
Document Number: 2024-23482
Type: Notice
Date: 2024-10-10
Agency: Drug Enforcement Administration, Department of Justice
Halowells Pharmacy; Decision and Order
Document Number: 2024-23495
Type: Notice
Date: 2024-10-10
Agency: Drug Enforcement Administration, Department of Justice
Salman Akbar, M.D.; Decision and Order
Document Number: 2024-23504
Type: Notice
Date: 2024-10-10
Agency: Drug Enforcement Administration, Department of Justice
Merry Alice Troupe, N.P.; Decision and Order
Document Number: 2024-23170
Type: Notice
Date: 2024-10-08
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Fresenius Kabi USA, LLC
Document Number: 2024-22450
Type: Notice
Date: 2024-10-01
Agency: Drug Enforcement Administration, Department of Justice
Fresenius Kabi USA, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Curia Wisconsin, Inc.
Document Number: 2024-22446
Type: Notice
Date: 2024-10-01
Agency: Drug Enforcement Administration, Department of Justice
Curia Wisconsin, Inc., has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.